FASEB J. Cell Migration Consortium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(The FASEB Journal. 2008;22:869.29)
© 2008 FASEB
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Chinkes, D. L
Right arrow Articles by Herndon, D. N
PubMed
Right arrow Articles by Chinkes, D. L
Right arrow Articles by Herndon, D. N
(The FASEB Journal. 2008;22:869.29.)
© 2008 FASEB


869.29

Comparison of A-V and precursor-product methods for measuring muscle protein breakdown in burned patients

David L Chinkes1,3, Xiao-Jun Zhang1, Asle Aarsland2, William B Norbury1, Arny A Ferrando4, Robert R Wolfe4 and David N Herndon1

1 Surgery
2 Anesthesia, University of Texas Medical Branch at Galveston, Galvestion, TX
3 Metabolism, Shriners Hospital, Galveston, TX
4 Dept of Geriatrics, Univ of Arkansas for Medical Sciences, Little Rock, AR

ABSTRACT

We have recently developed a new bolus precursor-product method for measuring protein synthesis and breakdown simultaneously. The new method is an attractive alternative to our previously developed A-V balance method because it does not require femoral lines or measurement of blood flow. Although we have previously shown that the two methods (A-V vs precursor-product) for measuring protein breakdown agree in rabbits, the new method has not been validated in humans. The purpose of this study was to compare muscle protein fractional breakdown rates (FBR) using the two methods in humans simultaneously. Results from the A-V balance method were converted to units %/h with estimates of muscle protein bound pool size. Five burn patients not on anabolic treatments were studied at 1 and 3 weeks postburn using both the A-V balance method (using 13C4 threonine tracers) and the new precursor-product method (using 15N and 13C6 phenylalanine tracers). FBR was similar for A-V (1 week: 0.29 ± 0.13%/h, n=3; 3 weeks: 0.29 ± 0.11%/h, n=5) and bolus (1 week: 0.24 ± 0.05 %/h, n=5; 3 weeks: 0.29 ± 0.05 %/h, n=4) methods. Comparable results are obtained with the new method using either arterial or peripheral venous enrichment. The new precursor-product bolus method gives similar results to the A-V balance method without the use of femoral catheters or measurement of blood flow.





This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Chinkes, D. L
Right arrow Articles by Herndon, D. N
PubMed
Right arrow Articles by Chinkes, D. L
Right arrow Articles by Herndon, D. N